Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET

被引:0
|
作者
Park, Yong-Jin [1 ]
Moon, So Young [2 ]
Yoon, Joon-Kee [1 ]
Lee, Su-Jin [1 ]
An, Young-Sil [1 ,3 ]
机构
[1] Ajou Univ, Dept Nucl Med & Mol Imaging, Sch Med, Suwon, South Korea
[2] Ajou Univ, Dept Neurol, Sch Med, Suwon, South Korea
[3] Ajou Univ, Sch Med, Dept Nucl Med & Mol Imaging, 206 World Cup Ro, Suwon 16499, Gyeonggi Do, South Korea
来源
EJNMMI RESEARCH | 2025年 / 15卷 / 01期
关键词
Amyloid; Positron emission tomography; Flutemetamol; Cutoff; CortexID suite; VALIDATION;
D O I
10.1186/s13550-024-01193-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background This study aimed to establish the optimal cutoff values for visual amyloid positivity using standardized uptake value ratios (SUVRs) in [F-18]flutemetamol (FMM) positron emission tomography (PET) imaging. Given the variability in amyloid assessment, our goal was to determine cutoff values that enhance diagnostic accuracy and assist clinicians in reliably identifying amyloid positivity. Results The identified cutoff values for visual amyloid positivity were > 1.6 for the cerebellar gray matter, > 1.38 for the whole cerebellum, and > 0.63 for the pons, yielding high sensitivity (95.5%, 94.5%, and 95.8%, respectively) and specificity (91.2%, 94.3%, and 95.2%, respectively). Conclusions The SUVR cutoff values demonstrated excellent diagnostic performance, supporting their clinical use in assessing visual amyloid positivity in [F-18]FMM PET imaging.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
    Juha O. Rinne
    Dean F. Wong
    David A. Wolk
    Ville Leinonen
    Steven E. Arnold
    Chris Buckley
    Adrian Smith
    Richard McLain
    Paul F. Sherwin
    Gill Farrar
    Marita Kailajärvi
    Igor D. Grachev
    Acta Neuropathologica, 2012, 124 : 833 - 845
  • [42] An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients
    Dean F. Wong
    Abhay R. Moghekar
    Daniele Rigamonti
    James R. Brašić
    Olivier Rousset
    William Willis
    Chris Buckley
    Adrian Smith
    Beril Gok
    Paul Sherwin
    Igor D. Grachev
    Molecular Imaging and Biology, 2013, 15 : 230 - 237
  • [43] Deep learning-based amyloid PET positivity classification model in the Alzheimer's disease continuum by using 2-[18F]FDG PET
    Kim, Suhong
    Lee, Peter
    Oh, Kyeong Taek
    Byun, Min Soo
    Yi, Dahyun
    Lee, Jun Ho
    Kim, Yu Kyeong
    Ye, Byoung Seok
    Yun, Mi Jin
    Lee, Dong Young
    Jeong, Yong
    EJNMMI RESEARCH, 2021, 11 (01)
  • [44] Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET
    Suhong Kim
    Peter Lee
    Kyeong Taek Oh
    Min Soo Byun
    Dahyun Yi
    Jun Ho Lee
    Yu Kyeong Kim
    Byoung Seok Ye
    Mi Jin Yun
    Dong Young Lee
    Yong Jeong
    EJNMMI Research, 11
  • [45] Decreased imaging time of amyloid PET using [18F]florbetapir can maintain quantitative accuracy
    Wagatsuma, Kei
    Ishibashi, Kenji
    Kameyama, Masashi
    Sakata, Muneyuki
    Miwa, Kenta
    Kamitaka, Yuto
    Ishii, Kenji
    RADIOLOGICAL PHYSICS AND TECHNOLOGY, 2022, 15 (02) : 116 - 124
  • [46] Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging
    Therriault, Joseph
    Benedet, Andrea L.
    Pascoal, Tharick A.
    Savard, Melissa
    Ashton, Nicholas J.
    Chamoun, Mira
    Tissot, Cecile
    Lussier, Firoza
    Kang, Min Su
    Bezgin, Gleb
    Wang, Tina
    Fernandes-Arias, Jaime
    Massarweh, Gassan
    Vitali, Paolo
    Zetterberg, Henrik
    Blennow, Kaj
    Saha-Chaudhuri, Paramita
    Soucy, Jean-Paul
    Gauthier, Serge
    Rosa-Neto, Pedro
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 247 - 252
  • [47] Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
    Therriault, Joseph
    Lussier, Firoza Z.
    Tissot, Cecile
    Chamoun, Mira
    Stevenson, Jenna
    Rahmouni, Nesrine
    Pallen, Vanessa
    Bezgin, Gleb
    Servaes, Stijn
    Kunach, Peter
    Wang, Yi-Ting
    Fernandez-Arias, Jaime
    Vermeiren, Marie
    Pascoal, Tharick A.
    Massarweh, Gassan
    Vitali, Paolo
    Soucy, Jean-Paul
    Saha-Chaudhuri, Paramita
    Gauthie, Serge
    Rosa-Neto, Pedro
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (03)
  • [48] Defining a Centiloid Scale threshold predicting long-term progression to dementia in patients attending the Memory Clinic: An [18F]-Flutemetamol amyloid-PET study
    Hanseeuw, B.
    Lhommel, R.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (02): : 138 - 139
  • [49] Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study
    Mammatas, Lemonitsa H.
    Venema, Clasina M.
    Schroder, Carolina P.
    de Vet, Henrica C. W.
    van Kruchten, Michel
    Glaudemans, Andor W. J. M.
    Yaqub, Maqsood M.
    Verheul, Henk M. W.
    Boven, Epie
    van der Vegt, Bert
    de Vries, Erik F. J.
    de Vries, Elisabeth G. E.
    Hoekstra, Otto S.
    Hospers, Geke A. P.
    van Oordt, C. Willemien Menke-van
    EJNMMI RESEARCH, 2020, 10 (01)
  • [50] [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer
    Been, Lukas B.
    Hoekstra, Harald J.
    Suurmeijer, Albert J. H.
    Jager, Pieter L.
    van der Laan, Bernard F. A. M.
    Elsinga, Philip H.
    ORAL ONCOLOGY, 2009, 45 (12) : E211 - E215